National Health Investors is a healthcare REIT with strong 37% margins, excellent free cash flow conversion, and analyst upside potential, but two consecutive earnings misses, negative price momentum, and a dividend coverage concern limit near-term entry attractiveness.
Thesis pillars
- Reit Quality Cash Conversion→Stable
- Consecutive Earnings Misses→Stable
- Price Momentum Below Trend↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
National Health Investors, Inc. (NHI) Stock Analysis
Falling Knife setup · Temporary headwind edge
Real Estate · REIT - Healthcare Facilities
Hold if already holding. Not a fresh buy at $66.92, but acceptable to hold if already in. Reasons: Thin upside margin: 6.4%; Sector modifier (Real Estate): -1.2.
National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176 properties ($2.7 billion gross carrying value) primarily leased under triple-net leases to 31 tenants in 32 states, plus 26 SHOP senior housing communities (3,009... Read more
Hold if already holding. Not a fresh buy at $66.92, but acceptable to hold if already in. Reasons: Thin upside margin: 6.4%; Sector modifier (Real Estate): -1.2. Chart setup: Death cross, below all MAs, RSI 24, MACD bearish. Growth is cheap relative to earnings, but the technical setup has not yet produced a breakout above resistance (PEG 0.46, quality 7.5/10, growth 10.0/10). | News modifier -1 (STRONG_BUY_WAIT → HOLD_IF_HOLDING) Score 6.5/10, moderate confidence.
Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 41d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.
About National Health Investors, Inc.
About National Health Investors, Inc.
National Health Investors generated $375.6 million in total revenues during 2025—a 12.1% increase over the prior year—from 176 triple-net-leased properties ($2.7 billion gross value) across 32 states leased to 31 tenants, plus 26 SHOP senior housing communities with 3,009 units operated by third-party managers. The portfolio comprised 110 senior housing properties, 65 skilled nursing facilities, and one hospital as of December 31, 2025. Rental income ($271.6 million, 72.3% of revenues), SHOP resident fees ($80.1 million, 21.3%), and interest and other income ($24.0 million, 6.4%) made up the revenue mix.
The company earns rental income through triple-net leases with initial terms of 10 to 15 years and one or more five-year renewal options; most leases include annual rent escalators recognized on a straight-line basis. Under the NNN structure, tenants pay taxes, utilities, insurance, and capital expenditures. The SHOP segment uses the RIDEA structure—NHI owns properties through consolidated partnerships (16 of 26 communities held in consolidated joint ventures) while third-party managers like Life Care Services operate them for a management fee. A $218.7 million note receivable portfolio, consisting of 11 mortgage loans at 7.3%–12.0%, nine mezzanine loans at 6.0%–10.0%, and four construction loans at 8.5%–9.0%, provides additional interest income and future acquisition optionality. NHI competes for healthcare real estate acquisitions with other REITs, private equity funds, banks, and insurance companies.
Show full overview
Tenant credit concentration is the dominant balance-sheet risk for NHI's Real Estate Investments segment. The 10-K discloses that a small number of tenants account for a significant percentage of rental income, and a board-level conflict of interest is flagged through a director who also chairs National HealthCare Corporation's (NHC) board. In April 2026, NHI entered a Purchase and Sale Agreement for NHC to acquire 32 skilled nursing facilities and three independent living facilities for $560 million—removing the NHC Master Lease from the portfolio and converting the company's largest tenant relationship into a one-time disposition that materially reshapes the Real Estate Investments segment.
See also: Real Estate · REIT - Healthcare Facilities
From National Health Investors, Inc.'s most recent 10-K filing, extracted June 11, 2026.
Recent developments
updated 2026-09-26Recent Developments — National Health Investors, Inc.
Latest news
- NEWS Lazard Asset Management LLC Makes New Investment in National Health Investors, Inc. $NHI - MarketBeat — MarketBeat positive
- NEWS National Health Investors CFO to retire; successor named - MSN — MSN neutral
- NEWS M&T Bank Corp Buys Shares of 39,236 National Health Investors, Inc. $NHI - MarketBeat — MarketBeat neutral
- NEWS Nhi Hiep Brick-Tile Co-Operation Faces Valuation Shift Amid Mixed Performance Indicators - Markets Mojo — Markets Mojo neutral
- NEWS National Health Investors is the most oversold real estate stock as Q1 earnings roll on - MSN — MSN negative
Generated 2026-09-26T04:42:01Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMTenantsmall number of tenants10-K Item 1A: 'A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio'
Material Events(8-K, last 90d)
- 2026-04-21Item 1.01MEDIUMNHI entered Purchase and Sale Agreement to sell 32 SNFs and 3 ILFs in AL, FL, KY, MO, SC, TN, and VA to NHC for $560M. Properties currently leased under the Master Lease dated October 17, 1991.SEC filing →
- 2026-04-21Item 1.02MEDIUMMaster Agreement to Lease with NHC/OP, L.P. to be terminated upon closing of the $560M property sale. Resolves the September 2025 default dispute with NHC.SEC filing →
- 2026-04-23Item 5.02MEDIUMCFO John L. Spaid notified intent to retire effective July 1, 2026; no disagreement with company cited. Successor Todd Siefert appointed EVP Corporate Finance effective June 1, 2026; will become CFO upon Spaid's retirement.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $66.92, but acceptable to hold if already in. Reasons: Thin upside margin: 6.4%; Sector modifier (Real Estate): -1.2. Chart setup: Death cross, below all MAs, RSI 24, MACD bearish. Growth is cheap relative to earnings, but the technical setup has not yet produced a breakout above resistance (PEG 0.46, quality 7.5/10, growth 10.0/10). | News modifier -1 (STRONG_BUY_WAIT → HOLD_IF_HOLDING) Target $71.23 (+6.4%), stop $64.53 (−3.7%), A.R:R 1.3:1. Score 6.5/10, moderate confidence.
Take-profit target: $71.23 (+6.4% upside). Target $71.23 (+6.4%), stop $64.53 (−3.7%), A.R:R 1.3:1. Stop-loss: $64.53.
Thin upside margin: 6.4%; Sector modifier (Real Estate): -1.2; Consecutive earnings misses (3).
National Health Investors, Inc. trades at a P/E of 19.4 (forward 20.7). TrendMatrix value score: 5.6/10. Verdict: Hold.
12 analysts cover NHI with a consensus score of 3.8/5. Average price target: $82.
What does National Health Investors, Inc. do?National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176...
National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176 properties ($2.7 billion gross carrying value) primarily leased under triple-net leases to 31 tenants in 32 states, plus 26 SHOP senior housing communities (3,009 units) operated by third-party managers.